Skip to Content


In the US, Ferumoxytol (ferumoxytol systemic) is a member of the drug class iron products and is used to treat Anemia Associated with Chronic Renal Failure and Iron Deficiency Anemia.

US matches:



CAS registry number (Chemical Abstracts Service)


Therapeutic Categories

Antianemic agent, treatment of iron deficiency

Diagnostic agent for magnetic resonance imaging (MRI)

Chemical Name

Non-stoichiometric magnetite (superparamagnetic iron oxide) coated with polyglucose sorbitol carboxymethylether

Foreign Name

  • Ferumoxytol (German)

Generic Names

  • Ferumoxytol (OS: USAN, BAN)
  • Code 7228 (IS)
  • Iron oxide, superparamagnetic (IS)

Brand Names

  • Feraheme
    AMAG, United States; Takeda Canada, Canada
  • Rienso
    Takeda, Finland; Takeda, Ireland; Takeda, Poland; Takeda Pharma, Slovenia


BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.